Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Devonian Health Group Inc (DVHGF)

Devonian Health Group Inc (DVHGF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Devonian Reports Results of its Annual General and Special Meeting of Shareholders PR Newswire - Mon Mar 30, 3:00PM CDT

QUÉBEC , March 30, 2026 /PRNewswire/ - Devonian Health Group Inc. (" Devonian " or the " Company ") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing...

DVHGF : 10.6500 (unch)
GSD.VN : 12.000 (-3.23%)
Devonian Health Group Inc. Reports Financial and Operating Results of its Three and Six Months Ended January 31, 2026 PR Newswire - Wed Mar 25, 3:22PM CDT

(all amounts are in Canadian dollars)

DVHGF : 10.6500 (unch)
GSD.VN : 12.000 (-3.23%)
Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine™, with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects PR Newswire - Thu Feb 19, 8:00AM CST

QUEBEC , Feb. 19, 2026 /CNW/ - Devonian Health Group Inc. ("Devonian" or the Company) (TSXV: GSD) (OTCQB: DVHGF) today announced positive results from a follow-up preclinical study evaluating...

DVHGF : 10.6500 (unch)
GSD.VN : 12.000 (-3.23%)
Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine™, with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects PR Newswire - Thu Feb 19, 8:00AM CST

QUEBEC , Feb. 19, 2026 /PRNewswire/ - Devonian Health Group Inc. ("Devonian" or the Company) (TSXV: GSD) (OTCQB: DVHGF) today announced positive results from a follow-up preclinical study evaluating...

DVHGF : 10.6500 (unch)
GSD.VN : 12.000 (-3.23%)
Devonian Advances Thykamine™ Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls PR Newswire - Tue Feb 17, 8:00AM CST

QUEBEC , Feb. 17, 2026 /PRNewswire/ - Devonian Health Group Inc. ("Devonian" or the Company) ( TSXV: GSD) (OTCQB: DVHGF) today announced that a proprietary Thykamine™ fingerprint has been...

DVHGF : 10.6500 (unch)
GSD.VN : 12.000 (-3.23%)
Devonian reports additional molecular data from MASH liver study PR Newswire - Thu Feb 12, 8:00AM CST

Gene expression analysis from the STAM mouse model attributes Thykamine™ with dose-dependent anti-MASH, anti-inflammatory and anti-fibrosis molecular effects in liver

DVHGF : 10.6500 (unch)
GSD.VN : 12.000 (-3.23%)
Devonian reports additional molecular data from MASH liver study PR Newswire - Thu Feb 12, 8:00AM CST

Gene expression analysis from the STAM mouse model attributes Thykamine™ with dose-dependent anti-MASH, anti-inflammatory and anti-fibrosis molecular effects in liver

DVHGF : 10.6500 (unch)
GSD.VN : 12.000 (-3.23%)
DEVONIAN REPORTS POSITIVE RESULTS IN PULMONARY FIBROSIS STUDY PR Newswire - Tue Feb 10, 8:00AM CST

QUÉBEC , Feb. 10, 2026 /PRNewswire/ - Devonian Health Group Inc. (" Devonian " or the " Company ") (TSXV: GSD); (OTCQB: DVHGF), a clinical stage corporation focused on developing unique...

DVHGF : 10.6500 (unch)
GSD.VN : 12.000 (-3.23%)
GSD : 11.25 (-0.88%)
DEVONIAN APPOINTS DENNIS TURPIN AS CHIEF FINANCIAL OFFICER AND PROVIDES UPDATES ON STOCK OPTIONS GRANT PR Newswire - Mon Feb 2, 7:45AM CST

QUÉBEC , Feb. 2, 2026 /PRNewswire/ - Devonian Health Group Inc. (" Devonian " or the " Company ") (TSXV: GSD) (OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions...

DVHGF : 10.6500 (unch)
GSD.VN : 12.000 (-3.23%)
DEVONIAN ANNOUNCES SHARE CONSOLIDATION IN FURTHER PREPARATION FOR POTENTIAL U.S. LISTING PR Newswire - Tue Jan 20, 8:00AM CST

QUÉBEC , Jan. 20, 2026 /PRNewswire/ - Devonian Health Group Inc. (" Devonian " or the " Company ") (TSXV: GSD) (OTCQB: DVHGF) is pleased to announce that, in connection with an evaluation...

DVHGF : 10.6500 (unch)
GSD.VN : 12.000 (-3.23%)

Barchart Exclusives

JPMorgan Stock Fans, Mark Your Calendars for April 14 Barchart - 2 minutes ago
JPMorgan is all set to publish its first-quarter results on April 14 following a strong 2025. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.